RecruitingNot Applicable

Augmented Endobronchial Ultrasound (EBUS-TBNA) With Artificial Intelligence

Norway50 participantsStarted 2023-05-01

Plain-language summary

To evaluate the usefulness of Deep neural network (DNN) in the evaluation of mediastinal and hilar lymph nodes with Endobronchial ultrasound (EBUS). The study will explore the feasibility of DNN to identify lymph nodes and blood vessel examined with EBUS.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Subjects referred to thoracic department in any of the participating hospitals with undiagnosed enlarged mediastinal and hilar lymph nodes. * Subjects have to be ≥ 18 years of age Exclusion Criteria: * Pregnancy * Any patient that the Investigator feels is not appropriate for this study for any reason.

What they're measuring

Capability

Timeframe: 8 months

Trial details

NCT IDNCT05739331

SponsorNorwegian University of Science and Technology

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-05-01

Contact for this trial

Øyvind Ervik, MD

+4791634595 oyvind.ervik@ntnu.no

View on ClinicalTrials.gov More Artificial Intelligence trials